Biotechnology company Pandorum Technologies has raised $18 million in a Series B funding round to advance and market tissue regenerative therapies. Pandorum specialises in programmable regenerative ...

Pandorum Technologies has raised $18 million in a Series B funding round to advance clinical development and expand market access for its regenerative therapies. The India and US-based biotechnology ...

Biotechnology firm Pandorum Technologies has raised $18 million (Rs 163 crore) in a Series B round to advance the clinical development of its therapies that target diseases on the surface of the eye.

For over 5 years, Arthur has been professionally covering video games, writing guides and walkthroughs. His passion for video games began at age 10 in 2010 when he first played Gothic, an immersive ...

The funding round led by Protons Corporate, with participation from Galentic Pharma, Noblevast Advisory and Avinya Fund, Burman Family, among others The fresh capital will be deployed to advance the ...

Pandorum Technologies, a biotechnology company focused on programmable regenerative medicine, has raised $18 million in a Series B funding round to advance clinical development and expand global ...

March 6, 2026: We checked for new Warframe codes. What are the new Warframe codes? If you're on the hunt for free glyphs and cosmetics, you're in luck - we've got a complete list of available codes ...

March 5, 2026 We checked for new DBD codes and verified our list. What are the latest DBD codes? These freebie-granting DBD rewards can reward you with anything from a few bonus Bloodpoints to help ...

What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...

For over 5 years, Arthur has been professionally covering video games, writing guides and walkthroughs. His passion for video games began at age 10 in 2010 when he first played Gothic, an immersive ...

BENGALURU, India & SAN CARLOS, Calif., February 09, 2026--(BUSINESS WIRE)--Pandorum Technologies, a biotechnology company pioneering programmable regenerative medicine, with operations in India and ...

QuantX will deploy Series B proceeds toward IND-enabling advancement of oral STAT6 and IL-17 inhibitors in immunology/inflammation and continued discovery expansion on its computational platform.